Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. GNTA
stocks logo

GNTA

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax
Wall Street analysts forecast GNTA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GNTA is 21.00 USD with a low forecast of 21.00 USD and a high forecast of 21.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast GNTA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GNTA is 21.00 USD with a low forecast of 21.00 USD and a high forecast of 21.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.860
sliders
Low
21.00
Averages
21.00
High
21.00
Current: 1.860
sliders
Low
21.00
Averages
21.00
High
21.00
no data image
No Data

Valuation Metrics

The current forward P/E ratio for Genenta Science SPA (GNTA.O) is -2.19, compared to its 5-year average forward P/E of -8.84. For a more detailed relative valuation and DCF analysis to assess Genenta Science SPA 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-8.84
Current PE
-2.19
Overvalued PE
-3.15
Undervalued PE
-14.52

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-4.96
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.29
Undervalued EV/EBITDA
-10.22

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
26.34
Current PS
0.00
Overvalued PS
86.25
Undervalued PS
-33.57
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

GNTA News & Events

Events Timeline

(ET)
2025-11-24
05:09:37
Genenta Science Offers Update on TEM-GBM Research Study
select
2025-10-24 (ET)
2025-10-24
05:06:19
Genenta Science and Anemocyte Form Partnership to Enhance Plasmid DNA Technology
select
2025-07-01 (ET)
2025-07-01
05:22:04
Genenta Science announces follow-up observations in glioblastoma study
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
2.0
11-24Newsfilter
Genenta Science Reports TEM-GBM Study Update, 44% 18-Month Survival Rate Achieved
  • Study Progress: As of November 21, 2025, Genenta Science has treated 25 patients with Temferon in newly diagnosed glioblastoma multiforme cases.
  • Survival Rate Improvement: The 18-month survival rate increased from 38% in April 2025 to 44%, indicating enhanced treatment efficacy.
  • Long-Term Survival Case: The first patient in the study survived 39 months post-Temferon treatment without additional therapies.
  • Financial Position: As of November 1, 2025, the company holds approximately $30 million in cash and short-term investments to support ongoing research.
[object Object]
Preview
9.5
11-20NASDAQ.COM
Earnings Growth Boosts PACS and Nutex; Zynex and Genenta Also Rise in After-Hours Trading

  • PACS Group Performance: PACS Group Inc. saw a significant after-hours surge of 45.48% to $24.48, following a strong quarterly report showing a net income increase to $52.4 million and revenue growth to $1.345 billion.

  • Zynex, Inc. Update: Zynex, Inc. experienced a 4.49% rise after hours to $0.58, despite reporting a net loss of $42.9 million for the quarter, down from a profit in the same period last year.

  • Genenta Science Recovery: Genenta Science S.p.A. rose 7.34% after hours to $1.90, recovering from a previous decline, with no new updates but a recent securities purchase agreement raising approximately $15 million.

  • Nutex Health Growth: Nutex Health Inc. advanced 9.64% after hours to $123.00, following a strong quarterly performance with a net income of $55.4 million and a revenue increase of 239.9% to $267.8 million.

[object Object]
Preview
9.5
10-29Benzinga
Teradyne Shares Surge Over 20%; Check Out 20 Stocks Making Moves in Premarket Trading

  • Teradyne's Strong Performance: Teradyne Inc. shares surged 20.7% in pre-market trading after reporting third-quarter earnings of 85 cents per share, exceeding analyst expectations of 79 cents, along with sales of $769.210 million, surpassing the $743.776 million estimate.

  • Notable Gainers: Several stocks saw significant pre-market gains, including Profusa Inc. (+72.8%), Founder Group Ltd (+59.4%), and Vsee Health Inc. (+44.3%), driven by positive developments such as manufacturing capacity increases and regulatory approvals.

  • Major Losers: Stride Inc. experienced a sharp decline of 36.4% after providing disappointing sales guidance, while Varonis Systems Inc. and Akebia Therapeutics Inc. also fell significantly due to lower-than-expected revenue and trial design issues, respectively.

  • Market Overview: The pre-market trading session showed a mix of gains and losses across various stocks, with notable movements in both directions, reflecting investor reactions to earnings reports and company announcements.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Genenta Science SPA (GNTA) stock price today?

The current price of GNTA is 1.86 USD — it has decreased -1.59 % in the last trading day.

arrow icon

What is Genenta Science SPA (GNTA)'s business?

Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.

arrow icon

What is the price predicton of GNTA Stock?

Wall Street analysts forecast GNTA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GNTA is 21.00 USD with a low forecast of 21.00 USD and a high forecast of 21.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Genenta Science SPA (GNTA)'s revenue for the last quarter?

Genenta Science SPA revenue for the last quarter amounts to NaN USD, decreased % YoY.

arrow icon

What is Genenta Science SPA (GNTA)'s earnings per share (EPS) for the last quarter?

Genenta Science SPA. EPS for the last quarter amounts to USD, decreased % YoY.

arrow icon

What changes have occurred in the market's expectations for Genenta Science SPA (GNTA)'s fundamentals?

The market is revising No Change the revenue expectations for Genenta Science S.p.A. (GNTA) for FY2025, with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -46.86%.
arrow icon

How many employees does Genenta Science SPA (GNTA). have?

Genenta Science SPA (GNTA) has 13 emplpoyees as of December 05 2025.

arrow icon

What is Genenta Science SPA (GNTA) market cap?

Today GNTA has the market capitalization of 43.58M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free